Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.

Publication

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.

Journal Paper/Review - Sep 1, 2022

Patel Kunjal, Huo Yanling, Jao Jennifer, Powis Kathleen M, Williams Paige, Kacanek Deborah, Yee Lynn M, Chadwick Ellen G, Shiau Stephanie, Jacobson Denise L, Brummel Sean S, Sultan-Beyer Leila, Kahlert Christian, Zash Rebecca, Seage George, ĀăąĆĉČĎ Ā ā Ă ă Ą ą Ć ć Ĉ ĉ Ċ ċ Č č Ď ď Đ đ Ē ē Ĕ ĕ Ė ė Ę ę Ě ě Ĝ ĝ Ğ ğ Ġ ġ Ģ ģ Ĥ ĥ Ħ ħ Ĩ ĩ Ī ī Ĭ ĭ Į į İ ı Ĳ ĳ Ĵ ĵ Ķ ķ ĸ Ĺ ĺ Ļ ļ Ľ ľ Ŀ ŀ Ł ł Ń ń Ņ ņ Ň ň ŉ Ŋ ŋ Ō ō Ŏ ŏ Ő ő Œ œ Ŕ ŕ Ŗ ŗ Ř ř Ś ś Ŝ ŝ Ş ş Š š Ţ ţ Ť ť Ŧ ŧ Ũ ũ Ū ū Ŭ ŭ Ů ů Ű ű Ų ų Ŵ ŵ Ŷ ŷ Ÿ Ź ź Ż ż Ž ž ſ

Citation

Patel K, Huo Y, Jao J, Powis K, Williams P, Kacanek D, Yee L, Chadwick E, Shiau S, Jacobson D, Brummel S, Sultan-Beyer L, Kahlert C, Zash R, Seage G, ĀăąĆĉČĎ Ā. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States. N Engl J Med 2022; 387:799-809.

Type

Journal Paper/Review (English)

Journal

N Engl J Med 2022; 387

Publication Date

Sep 1, 2022

Issn Electronic

1533-4406

Pages

799-809

Brief description/objective

Data on the effectiveness and safety of dolutegravir-based antiretroviral therapy (ART) for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy as compared with other ART regimens commonly used in the United States and Europe, particularly when initiated before conception, are limited.